Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06643936 · ClinicalTrials.gov registry record · NA
E3 Diabetes - Closing the Gap in Diabetes Control
A NA study of Type 2 Diabetes, sponsored by Rush University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06643936 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by Rush University Medical Center. The registered enrollment target is 150 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06643936, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by Rush University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to decrease the racial gap in type 2 diabetes control in African American and Latinx patients in Rush University Medical Center clinics.
Conditions Studied
Interventions
- BEHAVIORAL E3 Multidisciplinary Team
- BEHAVIORAL E3 Self-Guided Type 2 Diabetes Education
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-11-18 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06643936
The ClinicalTrials.gov registry entry for NCT06643936 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (86% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which E3 Multidisciplinary Team is the first listed.
NCT06643936 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06643936 about?
NCT06643936 is a clinical study titled "E3 Diabetes - Closing the Gap in Diabetes Control". This study aims to decrease the racial gap in type 2 diabetes control in African American and Latinx patients in Rush University Medical Center clinics.
What is the current status of trial NCT06643936?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-11-18. Estimated completion is 2026-04-01.
What conditions does trial NCT06643936 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
What interventions are being tested in trial NCT06643936?
The interventions under investigation include: E3 Multidisciplinary Team (BEHAVIORAL), E3 Self-Guided Type 2 Diabetes Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT06643936?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06643936 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.